title: Physical and functional interaction between p53 mutants and different isoforms of p73.
abstract: p53 is the most frequently inactivated tumor suppressor gene in human cancer, whereas its homologue, p73, is rarely mutated. Similarly to p53, p73 can promote growth arrest or apoptosis when overexpressed in certain p53-null tumor cells. It has previously been shown that some human tumor-derived p53 mutants can exert gain of function activity. The molecular mechanism underlying this activity remains to be elucidated. We show here that human tumor-derived p53 mutants (p53His175 and p53Gly281) associate in vitro and in vivo with p73 alpha, beta, gamma, and delta. This association occurs under physiological conditions, as verified in T47D and SKBR3 breast cancer cell lines. The core domain of mutant p53 is sufficient for the association with p73, whereas both the specific DNA binding and the oligomerization domains of p73 are required for the association with mutant p53. Furthermore, p53His175 and p53Gly281 mutants markedly reduce the transcriptional activity of the various isoforms of p73. Thus, human tumor-derived p53 mutants can associate with p73 not only physically but also functionally. These findings define a network involving mutant p53 and the various spliced isoforms of p73 that may confer upon tumor cells a selective survival advantage.
authors.affiliation: Molecular Oncogenesis Laboratory, Regina Elena Cancer Center, Via delle Messi d'Oro 156, Rome 00158, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Strano
authors.forename: E
authors.initials: E
authors.lastname: Munarriz
authors.forename: M
authors.initials: M
authors.lastname: Rossi
authors.forename: B
authors.initials: B
authors.lastname: Cristofanelli
authors.forename: Y
authors.initials: Y
authors.lastname: Shaul
authors.forename: L
authors.initials: L
authors.lastname: Castagnoli
authors.forename: A J
authors.initials: AJ
authors.lastname: Levine
authors.forename: A
authors.initials: A
authors.lastname: Sacchi
authors.forename: G
authors.initials: G
authors.lastname: Cesareni
authors.forename: M
authors.initials: M
authors.lastname: Oren
authors.forename: G
authors.initials: G
authors.lastname: Blandino
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000235:genetics* / Q000378:metabolism*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D016147:Genes, Tumor Suppressor; D016158:Genes, p53; D006801:Humans; D009154:Mutation; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism*; D011485:Protein Binding; D015533:Transcriptional Activation; D014407:Tumor Cells, Cultured; D000072160:Tumor Protein p73; D016159:Tumor Suppressor Protein p53 / Q000235:genetics* / Q000378:metabolism*; D025521:Tumor Suppressor Proteins
chemical_list: D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; C000606460:TP73 protein, human; D000072160:Tumor Protein p73; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins